Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Equity Ratio (2020 - 2025)

Rapid Micro Biosystems' Equity Ratio history spans 6 years, with the latest figure at 0.44 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 42.2% to 0.44 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.44, a 42.2% decrease, with the full-year FY2025 number at 0.44, down 42.2% from a year prior.
  • Equity Ratio hit 0.44 in Q4 2025 for Rapid Micro Biosystems, down from 0.53 in the prior quarter.
  • Over the last five years, Equity Ratio for RPID hit a ceiling of 0.92 in Q3 2021 and a floor of 1.27 in Q2 2021.
  • Historically, Equity Ratio has averaged 0.69 across 5 years, with a median of 0.83 in 2024.
  • Biggest five-year swings in Equity Ratio: surged 170.86% in 2022 and later plummeted 42.2% in 2025.
  • Tracing RPID's Equity Ratio over 5 years: stood at 0.92 in 2021, then fell by 6.02% to 0.86 in 2022, then dropped by 4.48% to 0.82 in 2023, then fell by 6.68% to 0.77 in 2024, then plummeted by 42.2% to 0.44 in 2025.
  • Business Quant data shows Equity Ratio for RPID at 0.44 in Q4 2025, 0.53 in Q3 2025, and 0.72 in Q2 2025.